- Home
- ARQT vs FBK Comparison
ARQT vs FBK Comparison
Compare ARQT & FBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- FBK
- Stock Information
- Founded
- ARQT 2016
- FBK 1906
- Country
- ARQT United States
- FBK United States
- Employees
- ARQT N/A
- FBK N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- FBK Major Banks
- Sector
- ARQT Health Care
- FBK Finance
- Exchange
- ARQT Nasdaq
- FBK Nasdaq
- Market Cap
- ARQT 2.1B
- FBK 2.1B
- IPO Year
- ARQT 2020
- FBK 2016
- Fundamental
- Price
- ARQT $17.71
- FBK $54.39
- Analyst Decision
- ARQT Strong Buy
- FBK Buy
- Analyst Count
- ARQT 7
- FBK 5
- Target Price
- ARQT $19.00
- FBK $59.00
- AVG Volume (30 Days)
- ARQT 1.6M
- FBK 293.1K
- Earning Date
- ARQT 11-05-2025
- FBK 10-14-2025
- Dividend Yield
- ARQT N/A
- FBK 1.44%
- EPS Growth
- ARQT N/A
- FBK N/A
- EPS
- ARQT N/A
- FBK 1.94
- Revenue
- ARQT $263,464,999.00
- FBK $410,807,000.00
- Revenue This Year
- ARQT $72.46
- FBK $34.11
- Revenue Next Year
- ARQT $31.69
- FBK $22.63
- P/E Ratio
- ARQT N/A
- FBK $27.22
- Revenue Growth
- ARQT 99.50
- FBK N/A
- 52 Week Low
- ARQT $8.03
- FBK $38.83
- 52 Week High
- ARQT $18.15
- FBK $58.88
- Technical
- Relative Strength Index (RSI)
- ARQT 63.97
- FBK 65.24
- Support Level
- ARQT $16.62
- FBK $51.62
- Resistance Level
- ARQT $18.15
- FBK $53.50
- Average True Range (ATR)
- ARQT 0.69
- FBK 1.12
- MACD
- ARQT 0.03
- FBK -0.18
- Stochastic Oscillator
- ARQT 85.57
- FBK 86.02
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.